{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "21842473",
  "DateCompleted": {
    "Year": "2012",
    "Month": "01",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "05"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2011",
        "Month": "08",
        "Day": "15"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/adma.201102313"
    ],
    "Journal": {
      "ISSN": "1521-4095",
      "JournalIssue": {
        "Volume": "23",
        "Issue": "36",
        "PubDate": {
          "Year": "2011",
          "Month": "Sep",
          "Day": "22"
        }
      },
      "Title": "Advanced materials (Deerfield Beach, Fla.)",
      "ISOAbbreviation": "Adv Mater"
    },
    "ArticleTitle": "Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.",
    "Pagination": {
      "StartPage": "H217",
      "EndPage": "H247",
      "MedlinePgn": "H217-47"
    },
    "Abstract": {
      "AbstractText": [
        "Cancer nanotheranostics aims to combine imaging and therapy of cancer through use of nanotechnology. The ability to engineer nanomaterials to interact with cancer cells at the molecular level can significantly improve the effectiveness and specificity of therapy to cancers that are currently difficult to treat. In particular, metastatic cancers, drug-resistant cancers, and cancer stem cells impose the greatest therapeutic challenge for targeted therapy. Targeted therapy can be achieved with appropriately designed drug delivery vehicles such as nanoparticles, adult stem cells, or T cells in immunotherapy. In this article, we first review the different types of nanotheranostic particles and their use in imaging, followed by the biological barriers they must bypass to reach the target cancer cells, including the blood, liver, kidneys, spleen, and particularly the blood-brain barrier. We then review how nanotheranostics can be used to improve targeted delivery and treatment of cancer cells. Finally, we discuss development of nanoparticles to overcome current limitations in cancer therapy."
      ],
      "CopyrightInformation": "Copyright \u00a9 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA."
          }
        ],
        "LastName": "Kievit",
        "ForeName": "Forrest M",
        "Initials": "FM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zhang",
        "ForeName": "Miqin",
        "Initials": "M"
      }
    ],
    "GrantList": [
      {
        "GrantID": "T32CA138312",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01EB006043",
        "Acronym": "EB",
        "Agency": "NIBIB NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01CA134213",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "T32 CA138312",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 EB006043",
        "Acronym": "EB",
        "Agency": "NIBIB NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA134213",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Adv Mater",
    "NlmUniqueID": "9885358",
    "ISSNLinking": "0935-9648"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Diagnostic Imaging"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Drug Delivery Systems"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Nanomedicine"
    },
    {
      "QualifierName": [
        "diagnosis",
        "metabolism",
        "pathology",
        "therapy"
      ],
      "DescriptorName": "Neoplasms"
    }
  ]
}